1. Home
  2. NBIX vs GNRC Comparison

NBIX vs GNRC Comparison

Compare NBIX & GNRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$131.88

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Logo Generac Holdlings Inc.

GNRC

Generac Holdlings Inc.

HOLD

Current Price

$218.51

Market Cap

11.8B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBIX
GNRC
Founded
1992
1959
Country
United States
United States
Employees
N/A
9400
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Metal Fabrications
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
11.8B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
NBIX
GNRC
Price
$131.88
$218.51
Analyst Decision
Strong Buy
Buy
Analyst Count
22
18
Target Price
$180.82
$209.06
AVG Volume (30 Days)
1.0M
822.8K
Earning Date
05-05-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
41.95
N/A
EPS
4.67
N/A
Revenue
$161,626,000.00
N/A
Revenue This Year
$24.73
$17.36
Revenue Next Year
$13.14
$12.51
P/E Ratio
$28.24
$84.89
Revenue Growth
977.51
N/A
52 Week Low
$101.15
$109.20
52 Week High
$160.18
$241.09

Technical Indicators

Market Signals
Indicator
NBIX
GNRC
Relative Strength Index (RSI) 51.80 60.47
Support Level $124.29 $195.41
Resistance Level $136.23 $238.55
Average True Range (ATR) 4.36 7.12
MACD 0.20 1.97
Stochastic Oscillator 72.29 96.95

Price Performance

Historical Comparison
NBIX
GNRC

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

About GNRC Generac Holdlings Inc.

Generac designs and manufactures power generation equipment serving residential, commercial, and industrial markets. It offers standby generators, portable generators, lighting, outdoor power equipment, and a suite of clean energy products. Sales generated in the United States account for the majority of total sales.

Share on Social Networks: